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Abstract
A moderate alcohol consumption is demonstrated to exert a protective action in terms of car-
diovascular risk. Although this property seems not to be beverage-specific, the various com-
position of alcoholic compounds could mediate peculiar effects in vivo. The aim of this study
was to evaluate potential beer-mediated effects on the cardiovascular health in humans,
using a meta-analytic approach (trial registration number: CRD42018118387). The literature
search, comprising all English articles published until November, 30th 2019 in EMBASE,
PubMed and Cochrane database included all controlled clinical trials evaluating the cardio-
vascular effects of beer assumption compared to alcohol-free beer, water, abstinence or
placebo. Both sexes and all beer preparations were considered eligible. Outcome parame-
ters were those entering in the cardiovascular risk charts and those related to endothelial
dysfunction. Twenty-six trials were included in the analysis. Total cholesterol was signifi-
cantly higher in beer drinkers compared to controls (14 studies, 3.52 mg/dL, 1.71–5.32 mg/
dL). Similar increased levels were observed in high-density lipoprotein (HDL) cholesterol
(18 studies, 3.63 mg/dL, 2.00–5.26 mg/dL) and in apolipoprotein A1 (5 studies, 0.16 mg/dL,
0.11–0.21 mg/dL), while no differences were detected in low density lipoprotein (LDL) cho-
lesterol (12 studies, -2.85 mg/dL, -5.96–0.26 mg/dL) and triglycerides (14 studies, 0.40 mg/
dL, -5.00–5.80 mg/dL) levels. Flow mediated dilation (FMD) resulted significantly higher in
beer-consumers compared to controls (4 studies, 0.65%, 0.07–1.23%), while blood pres-
sure and other biochemical markers of inflammation did not differ. In conclusion, the specific
beer effect on human cardiovascular health was meta-analysed for the first time, highlight-
ing an improvement of the vascular elasticity, detected by the increase of FMD (after acute
intake), and of the lipid profile with a significant increase of HDL and apolipoprotein A1
serum levels. Although the long-term effects of beer consumption are not still understood, a
beneficial effect of beer on endothelial function should be supposed.
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Introduction
Alcohol consumption is documented to exert multiple consequences on human health. Along-
side the well-known harmful effects of alcohol abuse, the real impact of moderate assumption
is more complex to elucidate. Several epidemiological studies described a J-shaped correlation
between alcohol intake and cardiovascular disease, depicting a dose-related combination of
beneficial and harmful effects [1]. Moderate drinkers show lower cardiovascular risk com-
pared to both heavy drinkers and abstainers [2–4]. Indeed, a moderate alcohol consumption,
defined as up to 1 drink (12 g of ethanol) daily for women and up to 2 for men, seems to have
beneficial effects on general health. In this context, an alcohol-mediated protective action is
largely proposed in the cardiovascular setting and numerous underlying mechanisms have
been advocated, such as high-density lipoprotein (HDL) increase, low-density lipoprotein
(LDL) decrease, reduction in platelet aggregation, beneficial effects on inflammation, anti-ath-
erogenesis and anti-thrombotic actions [5]. Although the qualitative difference between the
various alcoholic beverages does not seem to be decisive in reducing cardiovascular risk [6, 7],
the in vivo effects of wine, beer or spirit assumption result significantly different. Positive
effects of moderate alcohol consumption on mortality rate have been reported since the late
seventies [8] and have later been reviewed and confirmed by several other papers [9–11].
Indeed, recent meta-analyses demonstrated an overall beneficial effect of both wine and beer
consumption on cardiovascular risk and mortality, hypothesizing a fundamental action of the
polyphenol content, which is absent in spirits [2, 12–14]. In vitro studies suggest a wine-related
modulation in the expression of serum inflammatory and leucocyte adhesion molecules, such
as the increase of interleukin (IL)-10 and decrease of IL-1α, IL-6, intracellular adhesion mole-
cule (ICAM)-1, P-Selectin, monocyte chemoattractant protein (MCP)-1, and vascular cell-
adhesion molecule (VCAM)-1 [12]. While the molecular mechanisms of wine action have
been extensively studied, much less is known about beer effects, despite its widespread con-
sumption all over the world [14].
Beer is a product of cereals fermentation and it is composed for 90% by water and for the
remaining 10% by sugars, minerals, vitamins, amino acids, alcohol and polyphenols. Alongside
the barley and hops-derived polyphenols, other beer ingredients added to impart additional
flavours contribute to the polyphenolic content. In particular, the flavonoids depicted in beer
are flavan-3-ols (catechin, epicatechin and gallocatechin), flavanols (kaempferol, myricetin
and quercetin), and proanthocyanins. Among these, xanthohumol is a prenylated chalcone-
type flavonoid representing a beer-specific polyphenol, since it is present exclusively in hop-
derived products [15]. This molecule is suggested to confer beer-specific beneficial effects
compared to other fermented alcoholic beverages, but this aspect needs further confirmation
[13]. Yeasts are also used in the production of beer, as a means to make the drink alcoholic
and carbonated. These organisms also produce several compounds having protective effect
against degenerative diseases, such as melatonin, tryptophol and serotonin [16] which have
also shown beneficial properties in cardiovascular prevention [17–20]. Regarding the alcoholic
component, different kinds of beer are available with an alcohol content ranging from 3.5 to
10 percentage weight/volume (% w/v). A moderate beer consumption is defined by the World
Health Organization (WHO) as up to a can of 330 mL of beer containing about 5% w/v alcohol
daily for women and up to 2 for men [21]. The heterogeneous composition of beer represents
one of the most interesting challenge in evaluating effects of alcoholic beverages on human
health. Indeed, a hypothetical beneficial effect could be due to the action of either alcohol or
polyphenols alone or a synergic effect of both.
Despite the large amount of data investigating the effect of alcoholic beverages on human
health, a specific evaluation of the beer potential benefits is not available. Thus, the aim of this
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study was to provide a comprehensive evaluation of potential beer-mediated protective effects,
focusing on the endothelial health.
Materials and methods
Protocol
We performed this study according to the Cochrane Collaboration [22] and PRISMA
statement.
Data sources and strategies
A comprehensive literature search was performed using the following search key words: beer,
cardiovascular risk, cardiovascular disease, cardiovascular, endothelial function, endothelial
dysfunction, and the Boolean operators AND and OR. All articles published in English lan-
guage until November, 30th 2019 in EMBASE, PubMed and Cochrane databases were evalu-
ated. The meta-analysis was first registered in the International Prospective Register of
Systematic Reviews (PROSPERO registration number: CRD42018118387). Articles were
screened to exclude duplicates and trials not aimed at studying beer effects.
Eligibility criteria
The following inclusion criteria were considered: (i) controlled study design; (ii) adult patients
(older than 18 years); (iii) beer administration compared to alcohol-free beer, water, absti-
nence or placebo. Both sexes were considered eligible, as well as all beer preparations.
Data process and quality
Two authors extracted data from all randomized controlled trials (RCTs) selected with regard
to study design, year of publication, number of included/excluded subjects, inclusion and
exclusion criteria and type of intervention. Data about cardiovascular health were extracted
from included studies. Since several parameters have been proposed in the literature to evalu-
ate the cardiovascular health, a work diagram was created to highlight those parameters
reported in the vast majority of extracted studies. The primary endpoints considered in the
analysis were lipid parameters.
The quality of RCTs was assessed using the Cochrane Risk of bias tool.
The procedures followed were in accordance with the ethical standards of the responsible
institutional or regional committee on human experimentation or in accordance with the Hel-
sinki Declaration of 1975 as revised in 2013. Considering the meta-analytic study design, ethics
approval was not required.
Data synthesis and analysis
The available data were meta-analyzed using the Review Manager 5.2 software (Version 5.2.4
Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012), using the
random or fixed effect models, according to data heterogeneity. Heterogeneity between the
results of different studies was examined by inspecting the scatter in the data points and the
overlap in their confidence intervals and by performing chi-square tests and I2 statistics. When
I2 was higher than 60%, random effect model was used since it provides a more conservative
estimate of the overall effect, especially relevant when studies were of different design and
duration. Weighted mean differences and 95% confidence intervals were estimated for each
endpoint considered. The mean difference was calculated for each study included, using
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results reported as mean and standard deviation. When results were reported as median and
standard error, these were used to calculate appropriate results.
Publication biases were evaluated inspecting the funnel plot, according to Cochrane collab-
oration and PRISMA statement. Moreover, the Egger’s test was performed to exclude the pres-
ence of publication biases.
Sensitivity analyses were performed in order to reduce studies heterogeneity, considering
the duration of beer administration in each study enrolled. Indeed, the acute beer administra-
tion was separated from the chronic administration. The acute or chronic administration was
defined according to the amount of beer administered. In particular, the acute protocol pro-
vided a single beer assumption, followed by outcomes measurement. On the contrary, the
chronic protocol consisted of many beer administrations in a prolonged time-frame interval
and followed by the outcome detection. Sensitivity analyses were performed considering the
gender and the health status of the subjects for the significant parameters.
In order to evaluate the alcohol contribution to the potential beneficial effect, meta-regres-
sion analyses were performed considering the amount of alcohol used in each trial. Meta-
regression analyses were performed using RStudio Server Open Source Edit Version 0.99.902
2016 and R programming software.
Statistical significance was set at p<0.05.
Results
The literature search detected 2,526,967 studies. After duplicates removal and fitting the search
on clinical trials in humans, the final number of articles was 131,495. Among these studies, 69
papers were selected after title and abstract evaluation. Table 1 reported included studies char-
acteristics and S1 Table showed excluded studies and reasons for exclusion. Twenty-six RCTs
fully fulfilled inclusion and exclusion criteria and were used for data extraction [11, 14, 23–46]
(Fig 1). Among studies enrolled, five trials considered an acute beer administration.
The analysis was limited to those parameters entering in the cardiovascular risk charts and
those related to endothelial dysfunction. In general, the most reported parameters were: cho-
lesterol, blood pressure, tumor necrosis factor (TNF), IL-6, flow mediated dilation (FMD),
fibrinogen, body mass index (BMI), glucose, insulin, adiponectin and high sensitivity C-reac-
tive protein (hs-CRP). However, not all parameters were available in all studies. Thus, we per-
formed a work diagram (S1 Fig) in which the font dimension is directly related to the number
of studies reporting each parameter. Considering those parameters reported in the vast major-
ity of studies (S1 Fig), the analysis was limited to lipid profile, blood pressure, FMD, fibrino-
gen, adiponectin, hs-CRP, TNF and IL-6.
Total cholesterol was reported in 14 studies, comparing 548 beer drinkers and 532 controls.
Total cholesterol was significantly higher in study compared to control group (mean difference
3.52 mg/dL, 1.71 to 5.32 mg/dL, p<0.001, I2 = 65%) (Fig 2). Similar results were found when
beer was compared to either alcohol-free beer (mean difference 3.00 mg/dL, 0.51 to 5.49 mg/
dL, p = 0.020, I2 = 69%), or placebo/water (mean difference 3.92 mg/dL, 0.51 to 7.33 mg/dL,
p = 0.020, I2 = 60%) (Fig 2). Sensitivity analysis was applied to reduce the source of heterogene-
ity. In studies evaluating only chronic administration of beer, the difference between study
and control group was evident comparing beer to alcohol-free beer and not to placebo/water
(mean difference 1.92 mg/dL, -4.35 to 8.19 mg/dL, p = 0.550, I2 = 65%). Moreover, no differ-
ences were observed dividing studies neither by patients’ gender (p = 0.479) nor by health sta-
tus (p = 0.301). Meta-regression analyses showed no relationship between total cholesterol and
alcohol content (p = 0.652). Finally, no publication biases were found (p = 0.147).
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Table 1. Included studies characteristics.
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HDL cholesterol was reported in 18 studies, comparing 626 beer drinkers and 635 controls.
HDL cholesterol significantly improved in study compared to control group (mean difference
3.63 mg/dL, 2.00 to 5.26 mg/dL, p<0.001, I2 = 96%) (Fig 3). Similar results were found when
beer was compared to either alcohol-free beer (mean difference 4.51 mg/dL, 2.23 to 6.79 mg/
dL, p<0.001, I2 = 96%), or placebo/water (mean difference 2.59 mg/dL, 0.74 to 4.45 mg/dL,
p<0.001, I2 = 93%) (Fig 3). In particular, significant higher apolipoprotein A1 levels were
Table 1. (Continued)
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[ACTH = adrenocorticotropic hormone; ALAT = alanine aminotransferase; ASAT = aspartate aminotransferase; BMI = body mass index;
DHEAS = dehydroepiandrosterone sulfate; F = female; FMD = flow mediated dilation; GGT = gamma-glutamyltransferase; HDL = high density lipoprotein; hs-
CRP = high sensitivity C-reactive protein; IFN = interferon; IL-6 = interleukin 6; M = male; MMP3 = matrix metalloproteinase-3; MMP9 = matrix metalloproteinase-9;
MCP-1 = monocyte chemoattractant protein-1; NA: not available; PAI-1 = plasminogen activator inhibitor-1; TMP1 = tropomyosin 1; tPA = tissue plasminogen
activator; TNF = tumor necrosis factor; VCAM-1 = vascular cell adhesion protein 1].
https://doi.org/10.1371/journal.pone.0233619.t001
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detected in study group, compared to control group (mean difference 0.16 mg/dL, 0.11 to 0.21
mg/dL, p<0.001, I2 = 97%) (Fig 4). Sensitivity analysis confirmed these differences also consid-
ering exclusively studies assessing chronic administration of beer (mean difference 3.69 mg/
dL, 1.74 to 5.63 mg/dL, p<0.001, I2 = 92%). Similar results were obtained dividing studies
according to gender (p = 0.709), whereas, the significant change in HDL cholesterol was lost in
Fig 1. Flow diagram showing the literature search process.
https://doi.org/10.1371/journal.pone.0233619.g001
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non-healthy subjects (p<0.001). No relationship was found between HDL cholesterol and
alcohol content (p = 0.798). Finally, no publication biases were found (p = 0.485).
LDL cholesterol was reported in 12 studies, comparing 459 beer drinkers and 635 controls
(S2 Fig). LDL cholesterol was not significantly different between study and control groups
(mean difference -2.85 mg/dL, -5.96 to 0.26 mg/dL, p = 0.070, I2 = 95%) (S2 Fig). This lack of
difference was maintained also dividing studies considering alcohol-free beer (mean difference
-3.13 mg/dL, -6.73 to 0.47 mg/dL, p = 0.090, I2 = 94%), or placebo/water (mean difference
-2.36 mg/dL, -7.16 to 2.44 mg/dL, p = 0.330, I2 = 80%) (S2 Fig).
Triglycerides were reported in 14 studies, comparing 552 beer drinkers and 536 controls
(S3 Fig). Triglycerides serum levels were not significantly different between study and control
groups (mean difference 0.40 mg/dL, -5.00 to 5.80 mg/dL, p = 0.089, I2 = 91%) (S3 Fig). This
lack of difference was maintained also dividing studies considering alcohol-free beer (mean
difference 2.16 mg/dL, -7.89 to 12.22 mg/dL, p = 0.670, I2 = 96%), or placebo/water (mean dif-
ference -0.11 mg/dL, -1.94 to 1.71 mg/dL, p = 0.330, I2 = 0%) (S3 Fig). Sensitivity analysis
showed confirmed the lack of significant difference (mean difference 0.54 mg/dL, -1.80 to 2.87
mg/dL, p = 0.720, I2 = 92%).
Blood pressure was evaluated in 8 studies, comparing 363 to 347 subjects. Systolic blood
pressure did not differ between study and control groups (mean difference 0.74 mmHg, -0.76
to 2.24 mmHg, p = 0.580, I2 = 97%) (S4 Fig). Similar lack of difference was maintained consid-
ering alcohol-free beer (mean difference 1.01 mmHg, -1.41 to 3.43 mmHg, p = 0.410, I2 =
96%) and water/placebo (mean difference 0.07 mmHg, -2.30 to 2.43 mmHg, p = 0.960, I2 =
98%) (S4 Fig). Similarly, diastolic blood pressure did not differ between study and control
groups (mean difference 0.15 mmHg, -1.07 to 1.38 mmHg, p = 0.800, I2 = 98%), also
Fig 2. Forest plot reporting total cholesterol serum levels comparing study and control groups.
https://doi.org/10.1371/journal.pone.0233619.g002
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considering alcohol-free beer (mean difference 1.46 mmHg, -0.02 to 2.94 mmHg, p = 0.050, I2
= 94%) and water/placebo (mean difference -1.73 mmHg, -3.47 to 0.00 mmHg, p = 0.050, I2 =
98%) (S5 Fig). Sensitivity analysis showed confirmed the lack of significant difference (mean
difference 0.83 mmHg, -0.71 to 2.37 mmHg, p = 0.290, I2 = 97%).
FMD was reported in 4 studies, resulting significantly higher in the study group compared
to controls (mean difference 0.65%, 0.07 to 1.23%, p = 0.030, I2 = 85%) (Fig 5). Considering
other biochemical markers of inflammation, no differences were detected for TNF (5 studies,
Fig 3. Forest plot reporting high density lipoprotein (HDL) cholesterol serum levels comparing study and control groups.
https://doi.org/10.1371/journal.pone.0233619.g003
Fig 4. Forest plot reporting apolipoprotein A1 serum levels comparing study and control groups.
https://doi.org/10.1371/journal.pone.0233619.g004
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mean difference 0.00 ng/mL, -0.14 to 0.13 ng/mL, p = 0.960, I2 = 85%) (S6 Fig), IL-6 (5 studies,
mean difference -1.89 ng/mL, -3.97 to 0.19 ng/mL, p = 0.080, I2 = 91%) (S7 Fig), adiponectin
(4 studies, mean difference 0.22 microg/mL, -0.21 to 0.64 microg/mL, p = 0.310, I2 = 93%) (S8
Fig), and hs-CRP (4 studies, mean difference -0.07 microg/mL, -0.34 to 0.19 microg/mL,
p = 0.600, I2 = 69%) (S9 Fig). Sensitivity analysis was not performed, since the number of stud-
ies included is limited.
Publication bias was not evident in this setting (Fig 6). Risk of bias of was reported in S10
Fig, showing an overall good quality of RCTs included in the final analysis, considering selec-
tion, attrition and reporting biases. S11 Fig showed the risk of bias judged for each study
included in the analysis. Slightly relevant was the risk of performance and detection biases,
which reflected the difficulty to perform a real double-blind clinical trial in the setting of die-
tary influence on the cardiovascular health.
Discussion
In Europe, the most prevalent alcoholic beverages are beer, wine and spirits in different pro-
portions and beer represents, in several European countries, the most prevalent source of alco-
hol consumption (>50%). In this meta-analysis we evaluated, for the first time, the specific
effects of beer on human health, distinctly from other alcoholic beverages, such as wine and
Fig 5. Forest plot reporting flow mediated dilation (FMD) comparing study and control groups.
https://doi.org/10.1371/journal.pone.0233619.g005
Fig 6. Tunel plot for high density lipoprotein (HDL) cholesterol levels.
https://doi.org/10.1371/journal.pone.0233619.g006
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spirit. Beer consumption is associated with improvement of the vascular elasticity, detected by
the increase of FMD and of the lipid profile with a significant increase of HDL cholesterol lev-
els possibly sustained by a raise of apolipoprotein A1 serum levels.
The accumulation of cholesterol within macrophage in arterial wall and their transforma-
tion in foam cells represents the key step in the atherosclerosis progression. In this process,
HDL has a protective role, promoting the reverse cholesterol transport from peripheral tissues,
allowing the excretion of cholesterol out of the body [47]. Thus, considering its physiological
role in lipid asset homeostasis, low HDL cholesterol levels represent an independent risk factor
for cardiovascular diseases. Here, a relevant effect of beer consumption on cholesterol levels
has been demonstrated by an increase of total cholesterol. This increase is supported by a sig-
nificant raise of HDL level, regardless of a meaningless action on LDL and triglycerides. This is
in line with several reports reporting how moderate alcohol consumption may be associated
with an increase in either the concentrations or in the anti-oxidant properties of HDL choles-
terol [14, 48]. Moreover, the increase of apolipoprotein A1 may represent the mechanism at
the base of HDL increase. Padro et al. recently demonstrated that regular consumption of
moderate amount (2 cans daily for men and 1 for women) of traditional beer for 4 weeks pro-
moted atheroprotective properties of HDL, preventing LDL oxidation and inducing choles-
terol efflux from macrophage [14]. Interestingly, the beneficial effect of beer on HDL
cholesterol seems to be evident only in healthy subjects. This specific context should be further
analysed by proper-designed trials.
A meta-analytic approach does not allow to discriminate whether lipid modulation is due
to alcohol or to polyphenol compounds contained in beer products. Moreover, the alcoholic
beverages composition could be extremely heterogeneous, involving a large number of com-
pounds that could play a role in the detected final effect, maybe due to single or synergic mech-
anisms. As a confirm, meta-regression analyses do not highlight a direct effect of alcohol
content on lipid asset, suggesting the action of other molecules. The polyphenols capability to
affect the lipid metabolism raising HDL serum levels was suggested by a recent meta-analysis,
in which all the possible polyphenol food sources were considered [49]. However, in the pres-
ent work we considered only beer products, compared to placebo, water, abstinence or alco-
hol-free beers. Dividing the analysis according to the control group intervention and in
particular comparing beer with alcohol-free beer, we aimed to discriminate the alcohol-medi-
ated effects from those due to non-alcoholic components, such as polyphenols. Since the
increase in HDL levels remains evident comparing beer assumption to both alcohol-free beer
and water, the causal mechanism seems not to be an alcohol-specific competence. However, in
quantitative terms, a more consistent HDL increase is observed comparing beer to alcohol-
free beer than to water (4.51 versus 2.59 mg/dL), suggesting a leading role of alcohol, although
not confirmed in meta-regression analyses considering the entire group of studies. Accord-
ingly, previous in vitro studies on polyphenols derived from red wine, cocoa and green tea do
not show an HDL functionality enhancement [50]. Thus, this beer-related improvement in
lipid asset seems to be due mainly to the ethanol itself [15]. This effect could be related to the
alcohol dehydrogenase (ADH) activity that, on the other hand, is largely demonstrated to be
related to several alcohol-related diseases, such as liver [51] and esophageal squamous cell [52]
cancers.
The beer-specific polyphenol xanthohumol exhibits anti-inflammatory properties in in
vitro studies, inhibiting lipopolysaccharide (LPS)-induced cytokine, MCP-1 and IL-6 produc-
tion [53]. In addition, the beer polyphenol content is suggested to mediate other cardioprotec-
tive actions, such as the increase of endothelial progenitor cells (EPC) and EPC-mobilizing
factors, molecules able to repair endothelial damages [54]. However, in our study, we do not
highlight a beer-related improvement of TNF, IL-6, adiponectin and hs-CRP. This lack of
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polyphenol-mediated improvement in endothelial dysfunction parameters could be simply
attributable to the low number of RCTs evaluated or to the presence of other substances able
to counteract the polyphenol action [54]. However, an improvement of FMD is detected
despite the low number of studies, suggesting a strong effect of beer on endothelial cells and,
thus, on vasodilation. FMD is a marker of vascular elasticity generally evaluated at brachial
artery at baseline and after 5 minutes of arterial occlusion, showing a normal response to the
reactive hyperemia of about 7–15% [55]. Even if the mean increase after beer consumption is
only one tenth (0.65%) of the FMD normal value, the significance achieved despite the few
included studies suggests a consistent beer-mediated capability to induce vasodilatation. How-
ever, this beneficial effect on endothelial function comes mainly from studies in which an
acute beer administration is provided, confirming those studies in the literature in which a vas-
cular endothelial function improvement is described after acute beer intake [41]. Indeed, the
acute intake could lead to the heart rate increase, the peripheral arteries dilation and the blood
pressure reduction.
Beer consumption does not affect blood pressure, neither systolic nor diastolic. This effect
is in line with the different properties exhibited by the heterogeneous components of beer.
Indeed, the beer-mediated action on blood pressure is due to the vasodilator action of polyphe-
nol [56]. Accordingly, a blood pressure reduction is detected when polyphenols are adminis-
tered through different oral sources [49], as well as when non-alcoholic polyphenol beer
compounds are used [26]. On the other hand, the role of alcohol on blood pressure is still
debated. Although the role of excessive alcohol intake on hypertension as well as the blood
pressure improvement after alcohol reduction are well established [57], the action of moderate
consumption is challenging. However, a possible alcohol-mediated capability to counteract the
blood pressure-reducing action of beer polyphenols has already been suggested [54]. More-
over, age, gender and comorbidities of subjects enrolled represent independent factors able to
interfere with the blood pressure status evaluation.
An inverse dose-effect correlation between vascular events and alcohol consumption was
detected for wine [13, 58] and, more recently, for beer [13]. While a protective range of daily
wine consumption (from 10–21 g to 41–72 g) has been proposed, the paucity of available studies
do not allow to obtain the same result for beer or spirit [13]. In the studies considered in our
meta-analysis, beer is administered in randomized clinical settings in moderate dosages, i.e. less
than 330 mL daily. Although the identification of a range of beer safety is beyond the objectives
of the present meta-analysis, our results suggest that a moderate beer consumption could exert
beneficial effects either in prevention of dyslipidaemia or in vasodilation improvement.
The most reliable outcomes at evaluating the cardiovascular health remains the long-term
incidence of major cardiovascular events and the consequent mortality. However, epidemio-
logical studies on alcoholic beverages are limited to the impossibility to precisely assess the
type and the amount of alcohol consumed. On the contrary, RCTs allow studying specific
types and amounts of alcoholic beverages, although limiting the evaluation on indirect mark-
ers of cardiovascular diseases. Despite the clear advantages coming from a controlled clinical
setting, RCTs are not free of biases. Indeed, almost all studies included in the analysis did not
strictly consider the diet and the activity pattern, except with specific questionnaires [26].
Moreover, the different intervention used in control groups represents another important
limit. Indeed, 14 studies (53.8%) compared beer to alcohol-free beers, allowing at detecting
mainly the alcohol role, in spite of polyphenolic beer contents. Moreover, the dealcoholisation
process provokes a significant loss of non-alcoholic compounds, including polyphenols. Thus,
the polyphenol content of beer and alcohol-free beer is not necessarily the same. Finally, since
the brand of beers used in RCTs is not always reported, a sub-analysis considering beer styles
was not possible.
PLOS ONE Beer and cardiovascular health
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In conclusion, this is the first comprehensive meta-analysis evaluating beer properties in
the cardiovascular setting, suggesting that a moderate beer consumption could beneficially
affect HDL serum levels and blood vessels elasticity. However, whether any of our findings has
any clinical relevance is a question largely left unanswered, as the small effect sizes do not
allow us to reach definite conclusions in that direction. Although the long-term effects of beer
consumption are not still understood, a beneficial effect of beer on endothelial function should
be supposed.
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